News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Patel Sanj K
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2023 |
4
| Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 155,500 options to buy
@ $10.76, valued at
$1.7M
Granted 25,925 options to buy
@ $0 |
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 1,929 shares
@ $11.44, valued at
$22.1k
Granted 239,795 options to buy
@ $11.97, valued at
$2.9M
Granted 39,967 options to buy
@ $0
Exercised 6,569 options to buy
@ $0 |
|
| 04/11/2022 |
4
| Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 239,795 options to buy
@ $11.1, valued at
$2.7M
Granted 39,967 options to buy
@ $0 |
|
| 03/23/2022 |
4
| Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 5,446 shares
@ $10.98, valued at
$59.8k
Exercised 18,555 options to buy
@ $0 |
|
| 03/18/2022 |
4
| Patel Sanj K (Chairman & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 1,922 shares
@ $10.13, valued at
$19.5k
Exercised 6,569 options to buy
@ $0 |
|
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Patel Sanj K (Chairman & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 4,924 shares
@ $23, valued at
$113.3k
Sold 20,401 shares
@ $23.04, valued at
$470k
Sold 4,528 shares
@ $23, valued at
$104.1k
Sold 23,569 shares
@ $23.08, valued at
$544k
Sold 1,600 shares
@ $23.06, valued at
$36.9k
Sold 1,137 shares
@ $23.07, valued at
$26.2k
Exercised 4,924 options to buy
@ $1.59, valued at
$7.8k
Exercised 20,401 options to buy
@ $1.59, valued at
$32.4k
Exercised 1,600 options to buy
@ $1.59, valued at
$2.5k
|
|
| 10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2020 |
4
| Patel Sanj K (Chairman & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 180,000 options to buy
@ $15.5, valued at
$2.8M
|
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 09/19/2019 |
4
| Patel Sanj K (Chairman & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 190,000 options to buy
@ $8.83, valued at
$1.7M
|
|
| 03/06/2019 |
4
| Patel Sanj K (Chairman & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 187,000 options to buy
@ $17.92, valued at
$3.4M
|
|
| 09/24/2018 |
4
| Patel Sanj K (Chairman & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 125,000 options to buy
@ $30.93, valued at
$3.9M
|
|
| 05/29/2018 |
4
| Patel Sanj K (Chairman & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Converted 135,889 shares
@ $0
Bought 63,922 options to buy
@ $15.6438, valued at
$1000k
Converted 428,203 options to buy
@ $0
Converted 71,967 options to buy
@ $0
Converted 63,922 options to buy
@ $0 |
|
| 05/23/2018 |
3
| Patel Sanj K (Chairman & CEO) has filed a Form 3 on Kiniksa Pharmaceuticals, Ltd. |
| 09/22/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/12/2017 |
4
| Patel Sanj K (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $14.26, valued at
$156.9k
|
|
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/19/2016 |
3/A
| Patel Sanj K (Director) has filed a Form 3/A on Syros Pharmaceuticals, Inc. |
| 09/19/2016 |
4
| Patel Sanj K (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Patel Sanj K (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 05/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/29/2013 |
4
| Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 14,711 shares
@ $48.73, valued at
$716.9k
Sold 52,190 shares
@ $47.91, valued at
$2.5M
Sold 17,204 shares
@ $48.31, valued at
$831.1k
Sold 15,895 shares
@ $47.39, valued at
$753.3k
Exercised 8,251 options to buy
@ $0.95, valued at
$7.8k
Exercised 3,664 options to buy
@ $0.95, valued at
$3.5k
Exercised 20,000 options to buy
@ $1.7, valued at
$34k
Exercised 35,308 options to buy
@ $3.52, valued at
$124.3k
Exercised 16,882 options to buy
@ $1.7, valued at
$28.7k
Exercised 15,895 options to buy
@ $3.52, valued at
$56k
|
|
| 06/10/2013 |
4
| Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 128,000 options to buy
@ $40.32, valued at
$5.2M
|
|
| 02/22/2013 |
4
| Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 18,654 shares
@ $49.49, valued at
$923.2k
Sold 5,954 shares
@ $49.6, valued at
$295.3k
Sold 45,392 shares
@ $49.02, valued at
$2.2M
Exercised 18,654 options to buy
@ $0
Exercised 5,954 options to buy
@ $0.95, valued at
$5.7k
Exercised 45,392 options to buy
@ $0.95, valued at
$43.1k
|
|
| 12/17/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/06/2012 |
4
| Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 23,000 shares
@ $49.3413, valued at
$1.1M
Sold 12,000 shares
@ $48.1046, valued at
$577.3k
Exercised 23,000 options to buy
@ $0.95, valued at
$21.9k
Exercised 12,000 options to buy
@ $0.95, valued at
$11.4k
|
|
| 12/04/2012 |
4
| Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 5,000 shares
@ $48.8652, valued at
$244.3k
Sold 30,000 shares
@ $49.4164, valued at
$1.5M
Exercised 5,000 options to buy
@ $0.95, valued at
$4.8k
Exercised 30,000 options to buy
@ $0.95, valued at
$28.5k
|
|
| 09/05/2012 |
4
| Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 15,187 shares
@ $49.8794, valued at
$757.5k
Sold 54,813 shares
@ $49.3564, valued at
$2.7M
Exercised 15,187 options to buy
@ $0.95, valued at
$14.4k
Exercised 54,813 options to buy
@ $0.95, valued at
$52.1k
|
|
|
|
|